Pfizer Q3 FY25: where the revenue came from and where it went
The whole income statement of Pfizer for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 30 – Sep 28, 2025
- Reported
- Nov 4, 2025
Revenue$16.7B
−6% year over year
Gross profit$12.5B
75% margin
Operating profit−$3.6B
−21% margin
Net profit$3.5B
21% margin
Net profit is larger than what operations earned, because the statement adds $7.1B below it, under Tax benefit and other.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 16.7 | 100% | −6% |
| US | 10.7 | 64% | −11% |
| Developed markets | 3.7 | 22% | +8% |
| International emerging | 2.3 | 14% | +2% |
| Cost of revenue | −4.2 | 25% | |
| Gross profit | 12.5 | 75% margin | +5pp |
| SG&A | −3.2 | 19% | +1pp |
| Other | −12.8 | 77% | +0pp |
| Operating profit | −3.6 | −21% margin | +0pp |
| Tax benefit and other | 7.1 | ||
| Net profit | 3.5 | 21% margin | −4pp |
359 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest